大連熱電(600719.SH):2021年度擬向銀行申請20億元授信額度
格隆匯 3 月 19日丨大連熱電(600719.SH)公佈,公司召開第九屆董事會第十五次會議,通過關於2021年度向銀行申請授信額度的議案。
為確保公司生產經營和發展的資金需求,擬提請董事會以及股東大會授權公司向各家銀行申請總額20億元的綜合授信額度。公司已制訂嚴格的審批權限和程序,能有效防範風險。公司向銀行申請的授信額度最終以銀行實際審批的授信額度為準,具體使用金額將根據公司運營的實際需求確定。
如授信總額度獲得通過,在取得銀行對綜合授信額度的批覆後,請董事會授權公司財務部在授信額度範圍內辦理相關手續,在辦理每筆流動資金貸款、銀行承兑匯票、抵(質)押擔保等業務時,將不再逐項提請董事會審批。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.